Global Liver Transplantation Market accounted for $XX million in 2015 and is expected to grow at a CAGR of XX% to reach $XX million by 2022. Development in treatments, increasing favoured reimbursement policies, rising incidence of Hepatitis A, B and C are the factors driving the market growth. Sufficient number of liver donors, increasing waiting list to get a new liver and length of hospital stay and its charge are restraining the market. North America leads the market for liver transplantation followed by the European countries. Since, the accessibility of liver donors is limited; the market is not yet well recognized in the developing markets such as India, China and others.
Do Inquiry Before Purchasing Report Here:
By end user, hospitals and adult liver transplantation centers segments are expected to account for around 50% share in the global liver transplantation market. Based on treatment type, liver transplantation surgery is likely to register more than average CAGR over the forecast period owing to surgical techniques and innovations in living related liver transplantations.
Some of the key players in the market include Conatus Pharmaceuticals Inc., Thompson Surgical, Dompe Farmaceutici S.p.A., Integra Life sciences, Digna Biotech, S.L., Isogenis, Inc., Allosource, RedHill Biopharma Ltd, Aetna and UCLA Transplantation Services.
Type of treatments Covered:
• Post-Surgery Anti-Rejection Treatment
o Mycophenolate Mofetil
• Liver Transplantation Surgery
Request For Report Sample Here:
End Users Covered:
• Adult Liver Transplantation Centers
• Ambulatory Surgical Centers
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o South Africa
Market Research Store is a single destination for all the industry, company and country reports. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations.